Nutrition

Caffeine

search

Caffeine, Caffeine Overdose, Caffeine Toxicity, Guaranine, Theine

  • See Also
  1. Unknown Ingestion
  • Indications
  1. Central Nervous System Stimulant
    1. Caffeine is the most widely used psychoactive substance in the world
    2. Daly (1998) Lakartidningen 95(51-52):5878-83 [PubMed]
  2. Idiopathic Apnea of Prematurity
    1. Increases central inspiratory drive
    2. Increases carbon dioxide sensitivity at respiratory centers in Medulla
    3. Increases skeletal Muscle contractility (including respiratory Muscles)
  3. Sports Performance Supplement (Ergogenic Aid)
    1. Athletes are limited to 12-15 mcg/ml urine depending on regulatory agency (NCAA, IOC)
    2. Performance enhancing in endurance sports
  • Preparations
  • Relative Caffeine amounts
  1. 10 mg/serving
    1. Decaffeinated coffee (7 oz, 210 ml)
    2. Milk chocolate (1.5 oz)
  2. 30 mg/serving
    1. Dark chocolate (1.5 oz)
  3. 50 mg/serving
    1. Tea (8 oz, 240 ml)
    2. Caffeinated soda (12 oz, 360 ml)
    3. Coffee ice cream (8 oz, 240 ml)
  4. 100 mg/serving
    1. Coffee (8 oz, 240 ml)
  5. 150 mg/serving
    1. Expresso (2 oz, 60 ml)
  6. 250-350 mg/serving
    1. Energy Drinks (8-16 oz, e.g. Redline, Spike, Hyde, Wired, Loud, Java Monster, Rockstar, Bang)
  • Precautions
  1. Energy drinks contain high levels of stimulants
    1. Combined Caffeine and Methylxanthines may exceed 500 mg total
    2. Higher risk of toxicity
  2. Limit daily Caffeine below maximum
    1. Adults: 400 mg/day
    2. Teens: 2.5 mg/kg/day (up to 400 mg/day)
  • Pathophysiology
  • Toxicity
  1. Adenosine Receptor Antagonist
  2. Stimulates Catecholamines (increased beta-1 and beta-2 agonist activity)
  3. Phosphodiesterase Inhibitor (increased 3-5 cAMP, increased intracellular Calcium)
  • Pharmacokinetics
  1. Metabolism: Zero order elimination (very slow elimination)
  2. Hepatic Metabolism
  3. High oral bioavailability
  4. Oral onset of peak activity <2 hours
  5. Half-Life: 4-5 hours (as long as 60-100 hours in newborns)
  6. Volume of distribution: 0.6 to 0.7 L/kg (0.8 to 0.9 in newborns)
  7. Protein binding: 17%
  8. Concentrations
    1. Toxicity: >35 mg/kg (esp. children)
    2. Lethal Dose: 10-20 grams in an adult (>100 mg/kg)
  • Adverse Effects
  • Non-toxic Ingestion
  1. Anxiety
  2. Jitteriness
  3. Arrhythmia
  4. Insomnia
  • Adverse Effects
  • Toxic Levels
  1. General
    1. Hypothermia
  2. Cardiopulmonary
    1. Respiratory Depression
    2. Dysrhythmia (e.g. Multifocal Atrial Tachycardia)
    3. Hypertension
    4. Wide Pulse Pressure (with diastolic Hypotension)
  3. Gastrointestinal
    1. Nausea
    2. Vomiting
  4. Neuropsychiatric
    1. Anxiety
    2. Tremor
    3. Seizures
  • Labs
  • Toxicity
  1. Consider evaluation for Unknown Ingestion
  2. Caffeine concentration is not typically available outside tertiary centers
  3. Basic Chemistry Panel
    1. Hypokalemia
    2. Metabolic Acidosis
    3. Hyperglycemia
  • Management
  • Severe Caffeine Toxicity or Overdose
  1. General
    1. Consider other ingestions
    2. Consider Poison Control Consultation
  2. Antidotes
    1. Consider Activated Charcoal after recent known large ingestion
    2. Consider Intralipid (20% lipid emulsion) 1.5 mg/kg for refractory Hypotension or tachydysrhythmia
  3. Supportive care
    1. ABC Management
    2. Vasopressors for Hypotension (e.g. Norepinephrine, Vasopressin)
    3. Consider Esmolol infusion for tachydysrhythmia (Exercise caution)
    4. Consider Benzodiazepines for Agitation
  4. Hemodialysis Indications
    1. Seizures
    2. refractory Hypotension or tachydysrhythmia
    3. Caffeine concentration at toxic levels (>100 mg/L acutely, >60 mg/L chronically)
  5. Discharge Indications
    1. Asymptomatic at 4-6 hours after ingestion
  • Resources
  1. FDA News: Investigation into Energy Drinks and Supplements
    1. http://www.fda.gov/Food/NewsEvents/ucm328536.htm
  • References
  1. Leikin (1996) Poisoning and Toxicology Handbook, Lexicomp, Hudson, Ohio, p. 175-7
  2. Nordt in Herbert (2012) EM: Rap 12(8): 5
  3. Tomaszewski (2019) Crit Dec Emerg Med 33(12): 32